Amalgam Rx, Inc. — Form D

Amalgam Rx, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-08. The offering totals $750K, of which $650K was reported sold. Industry: Other Health Care.

Offering

Filed: 2019-10-08
Form: D
Accession: 0001667234-19-000004
Industry: Other Health Care
Exemptions: 06b
Total offering: $750K
Amount sold: $650K
Remaining: $100K
Investors: 5
Date of first sale: 2019-09-23
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-350563

Issuer

Name: Amalgam Rx, Inc.
CIK: 0001667234
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2016
Address: 206 ALAPOCAS DRIVE, WILMINGTON, DE, 19803
Phone: 302 983 0001

Officers, directors & promoters (11)

Name	Role	Location
Sarwar A Islam	Director	Wilmington, DE
Ryan A Sysko	Director	Wilmington, DE
Ryan A Sysko	Executive Officer	Wilmington, DE
SONNY P VU	Director	WILMINGTON, DE
JEFFREY P COURTNEY	Director	WILMINGTON, DE
Sonny Vu	Director	Tel Aviv, L3
Ryan Sysko	Director	Baltimore, MD
Ryan Sysko	Executive Officer	Baltimore, MD
Jeffrey Courtney	Director	Wilmington, DE
Ryan Adam Sysko	Director	Wilmington, DE
Ryan Adam Sysko	Executive Officer	Wilmington, DE

Other filings by this issuer (6)

Filed	Form	Offering	Sold
2025-08-15	D	$7.9M	$7.9M
2023-01-03	D	$45.0M	$17.4M
2019-05-03	D/A	$2.0M	$1.2M
2019-03-06	D/A	$2.0M	$998K
2017-06-30	D	$2.0M	$95K
2016-03-24	D	$500K	$215K

More